Logged in as:
Advanced Search
Configure detailed search parameters with boolean logic
Search Parameters
Live Query Preview
Database-Specific Options
Study Search Fields
Study Status
Geographic
Study Features
AI is analyzing your request...
Processing natural language query
Advanced Search
Define your core search parameters with advanced boolean logic
Timeline Configuration
Live Query Preview
Real-time visualization of your search configuration
Database-Specific Search Options
ClinicalTrials.gov
400,000+ clinical studies from around the world
Study Search Fields
Study Status & Design
Participants & Demographics
Geographic & Advanced
Save & Execute Search
Ask Leaf Intelligence AI
Get instant, comprehensive answers about pharmaceutical regulations, clinical trials, FDA approvals, and drug safety. Upload documents for analysis.
Choose Research Depth
Select how thoroughly AI should analyze your query
Leaf AI can make mistakes. Your data is not used to train AI models.
FDA Complete Response Letters 0 found
FDA Complete Response Letters for regulatory review and compliance
Search Results
FDA Complete Response Letters
Perform a search to view relevant FDA Complete Response Letters for this drug
Search Overview
Clinical Trials
-
studies found
FDA Data
-
items found
EMA Data
-
items found
PubMed
-
articles found
Quick Actions
Analyzing FDA Data
Searching across multiple databases and applying AI intelligence...
Analyzing Regulatory Data
FDA Approved Drugs
Regulatory Milestones
Approval Statistics
No Regulatory Data Found
Unable to find regulatory information for that search term.
PubMed Search
TEG 6S Search in neonates
Viscoelastic coagulation Monitor Search in neonates
European Medicines Agency Information
Regulatory data across 11 specialized collections
Searching across 11 EMA collections...
Ready to Search All EMA Collections
Search across 11 comprehensive European regulatory databases:
Error Loading Data
An error occurred while searching EMA data.
No Results Found
No EMA data found across any of the 11 collections.
Try searching for:
Orange Book Information
DailyMed Information
Application Details
Company Analysis
Notes & Annotations
Upload Label
XML Label Management
Upload New XML Label
Uploaded Labels
Label Comparison
0
Added
0
Removed
0
Modified
0
Unchanged
0
Total Changes
Analyzing Pharmaceutical Label
Extracting: Active Ingredients
Applications
0
Companies
0
Label Versions
0
Changes
0
Latest Update
-
FDA Applications
Label Changes Analysis
No results found
Try searching with a different drug name or compound
📋 Labelling Information
Searching pharmaceutical databases...
📊 Labelling Overview
📋 Labels
🔍 Search pharmaceutical compounds
Enter a drug name to access comprehensive labeling information
📋 Label Information
FDA Approval Data
FDA Documents
Data sourced from FDA.gov, DailyMed, and FDA Orange Book. Last updated: March 2025
FDA Warning Letters
No Results Found
We couldn't find any FDA data for these companies. Try different company names or check your spelling.
Total Manufacturers
0
With FEI Numbers
0
Total FEI Numbers
0
Without FEI
0
Searching FDA databases...
This may take a few moments
FDA & Clinical Intelligence
Comprehensive regulatory landscape for
FDA Approved drugs
Drugs granted approval status by the FDA for the condition
| Brand Name ↕ | Generic Name ↕ | Manufacturer ↕ | Review Priority | Route | Approval Date ↕ | Status | NDC | Actions |
|---|
Approval Timeline
Drug Classification
Route Distribution
TEG 6S Clinical Research Dashboard
Comprehensive analysis of neonatal & pediatric applications
Key Neonatal Research Findings
Critical Research Gap Identified
No TEG 6S trials include neonates or premature infants in the dataset. The youngest age group in current trials is 3 months to 18 years (NCT05874843).
Blood Collection Method
All trials use citrated blood (3.2% citric acid) and require reactivation before analysis. No small-volume protocols for neonates identified.
Neonatal Applications
Potential neonatal concerns (tiny blood volumes, different coagulation values) not addressed in any identified trials or publications.
FDA Clearance Status
TEG 6S received FDA 510(k) clearance in 2019 (K183160) with an updated cartridge in 2024. No specific neonatal clearance documented.
Search & Filter Trials
Age Range Summary
| Trial ID | Age Range | Neonatal Inclusion | Relevant Population |
|---|
TEG 6S Clinical Trials
|
Trial ID
|
Title
|
Sponsor |
Registration Date
|
Status | Age Range | Actions |
|---|
Neonatal Research Gap Analysis
Current Limitations
- No trials include neonates (<28 days) or premature infants
- Youngest cohort: 3 months to 18 years (NCT05874843)
- Blood volume constraints of neonates not addressed in any protocols
- No specific neonatal reference ranges available for TEG 6S parameters
- Citrated blood draw procedures not validated for very small volume collections
Clinical Implications
- Premature and newborn infants have distinct coagulation profiles compared to older children and adults
- Standard blood collection volumes may be excessive for neonates with limited blood volume
- Interpretation of TEG 6S results in neonates would require specific reference ranges
- Risk/benefit ratio of TEG 6S testing in neonates has not been formally assessed
Research Opportunities
- Validation study of TEG 6S in neonatal populations with age-appropriate reference ranges
- Development of micro-sampling techniques compatible with TEG 6S cartridges
- Comparison of citrated vs. non-citrated samples in neonatal blood
- Assessment of minimal blood volume requirements for valid results
Overall Drug Success Rates
Treatment Efficacy Comparison Across Trials
This visualization combines data from all trials to show overall effectiveness of treatments. Higher values indicate better outcomes relative to placebo.
Response Rate Distribution
Percentage of patients who responded to treatment
Remission Rate Distribution
Percentage of patients who achieved remission
Statistical Summary by Drug
| Drug | Trials | Total Patients | Avg. Effect Size | Response Rate | Remission Rate |
|---|
Results Overview
Collated Trial Outcomes
Overall Treatment Effect Distribution
Phase Comparison
Compare effect sizes across different clinical trial phases. Higher values indicate better outcomes.
Comparative Phase Performance
Direct comparison of phase-specific effect sizes with confidence intervals.
Statistical Summary
| Phase | Trials | Mean Effect | Standard Deviation | 95% CI | p-value |
|---|